Clinical Trial Update: Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial update on combination chemotherapy for intermediate-grade or immunoblastic non-Hodgkin's lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 3 | Status: COMPLETED